Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Hugo, Mananet"'
Autor:
Nicolas Roussot, Marion Thibaudin, Jean-David Fumet, Susy Daumoine, Léa Hampe, Cédric Rébé, Emeric Limagne, Aurélie Lagrange, Victor Herreros, Julie Lecuelle, Hugo Mananet, Alis Ilie, David Rageot, Romain Boidot, Vincent Goussot, Anthony Comte, Pierre Jacob, Françoise Beltjens, Anthony Bergeron, Céline Charon-Barra, Laurent Arnould, Valentin Derangère, Sylvain Ladoire, Caroline Truntzer, François Ghiringhelli
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
A patient with a PD-L1-negative, TMB-low, KEAP1/STK11 co-mutated metastatic non-small cell lung cancer (NSCLC) experienced a multisite radiological progression at 3 months after initiation of chemoimmunotherapy as first-line treatment for metastatic
Externí odkaz:
https://doaj.org/article/720f9ebdb12b41d5a9b653e489118e2d
Autor:
Elise Ballot, Loïck Galland, Hugo Mananet, Romain Boidot, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Anthony Bergeron, Valentin Derangère, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire
Publikováno v:
Breast Cancer Research, Vol 24, Iss 1, Pp 1-16 (2022)
Abstract Purpose The vast majority of research studies that have described the links between DNA damage repair or homologous recombination deficiency (HRD) score, and tumor biology, have concerned either triple negative breast cancers or cancers with
Externí odkaz:
https://doaj.org/article/aae1a74ab7764d138f14f99a0499bf34
Autor:
Loïck Galland, Elise Ballot, Hugo Mananet, Romain Boidot, Julie Lecuelle, Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Anthony Bergeron, Valentin Derangère, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire
Publikováno v:
npj Breast Cancer, Vol 8, Iss 1, Pp 1-12 (2022)
Abstract Metastatic breast cancer (MBC) is frequently managed by platinum-based chemotherapy during the disease course. The real benefit of these treatments is uncertain at advanced stages of the disease and in non-triple-negative subtypes. Since hom
Externí odkaz:
https://doaj.org/article/8c75168bd84843898eaa4679c7af4e30
Autor:
Lorraine Dalens, Julie Lecuelle, Laure Favier, Cléa Fraisse, Aurélie Lagrange, Courèche Kaderbhai, Romain Boidot, Sandy Chevrier, Hugo Mananet, Valentin Derangère, Caroline Truntzer, François Ghiringhelli
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 8, p 7592 (2023)
Immune checkpoint inhibitors (ICIs) have improved the care of patients in multiple cancer types. However, PD-L1 status, high Tumor Mutational Burden (TMB), and mismatch repair deficiency are the only validated biomarkers of efficacy for ICIs. These m
Externí odkaz:
https://doaj.org/article/f31cce86d33c478ba3751d2f5429b6dd
Autor:
sylvain Ladoire, Elise Ballot, Loïck Galland, Hugo Mananet, Romain Boidot, Laurent Arnould, Isabelle Desmoulins, Didier Mayer, Courèche Kaderbhai, Sylvia Ilie, Audrey Hennequin, Anthony Bergeron, Valentin Derangère, Caroline Truntzer, Francois Ghiringhelli
Publikováno v:
Breast Cancer Research. 24
Purpose The vast majority of research studies that have described the links between DNA damage repair or homologous recombination deficiency (HRD) score, and tumor biology, have concerned either triple negative breast cancers or cancers with mutation
Autor:
Sandy, Chevrier, Astrid, Brasselet, Marion, Carnet, Angélique, Chevriaux, Anne, Gibeaud, Marine, Jourdain, Hugo, Mananet, Caroline, Truntzer, Françoise, Beltjens, Céline, Charon-Barra, Laurent, Arnould, Juliette, Albuisson, Anthony, Comte, Valentin, Derangère, Vincent, Goussot, Romain, Boidot
Publikováno v:
International Journal of Molecular Medicine. 49
Molecular testing is extremely important in cancer care, starting as early as at diagnosis. In order to address the challenge of providing reliable results within the timeframe adapted to patient management and suitable to guide clinical decisions, a
Autor:
François Ghiringhelli, Isabelle Ray Coquard, Hugo Mananet, Caroline Truntzer, Zoé Tharin, Jean-David Fumet, Julie Lecuelle, Juliette Albuisson, Valentin Derangère, Laurent Arnould, Vincent Goussot, Romain Boidot
Publikováno v:
Cancers
Volume 13
Issue 17
Cancers, Vol 13, Iss 4394, p 4394 (2021)
Volume 13
Issue 17
Cancers, Vol 13, Iss 4394, p 4394 (2021)
Simple Summary High-grade serous ovarian carcinoma (HGSC) could be analyzed with a molecular stratification defined by different genomic instability signatures associated with specific mutational process and prognostic biomarkers. Immune infiltrate i
Autor:
Thomas Collot, Sandy Chevrier, Hugo Mananet, Romain Boidot, Corentin Richard, Laurent Arnould
Publikováno v:
Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3113, p 3113 (2021)
Volume 13
Issue 13
Cancers, Vol 13, Iss 3113, p 3113 (2021)
Simple Summary PARP inhibitors, a family of targeted cancer therapeutics, have been shown to be efficient in patients with some deficiencies in the homologous recombination machinery. However, a quick and reliable identification of patients who would
Autor:
Loïck Galland, Elise Ballot, Hugo Mananet, Romain Boidot, Julie Lecuelle, Juliette Albuisson, Laurent Arnould, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhai, Silvia Ilie, Audrey Hennequin, Anthony Bergeron, Valentin Derangère, François Ghiringhelli, Caroline Truntzer, Sylvain Ladoire
Publikováno v:
NPJ breast cancer. 8(1)
Metastatic breast cancer (MBC) is frequently managed by platinum-based chemotherapy during the disease course. The real benefit of these treatments is uncertain at advanced stages of the disease and in non-triple-negative subtypes. Since homologous r